Luk J M, Nnalue N A, Lindberg A A
Department of Clinical Bacteriology, Karolinska Institute, Huddinge Hospital, Sweden.
J Immunol Methods. 1990 May 25;129(2):243-50. doi: 10.1016/0022-1759(90)90445-2.
A variety of different immunogens and immunisation schemes were investigated for the production of monoclonal antibodies directed against the O antigenic polysaccharide of the lipopolysaccharide (LPS) of Salmonella serogroup C1 (O:6,7). Of 12 fusions performed, higher yields of stable, LPS-reactive hybridomas producing monoclonal antibodies were achieved in both the mouse and rat when using O:6,7 LPS-coated S. thompson bacteria as immunogens than with live and heat-killed bacteria, or O:6,7-BSA glycoconjugate as immunogens. All of the 17 hybrid clones obtained were shown to bind the O antigens of Salmonella serogroup C1 when tested in ELISA against a set of chemically defined LPS from Salmonella smooth and rough strains. The results are discussed with a view to bettering the immunisation strategy for production of monoclonal antibodies against the LPS antigens of bacteria.
为了生产针对沙门氏菌血清群C1(O:6,7)脂多糖(LPS)的O抗原多糖的单克隆抗体,研究了多种不同的免疫原和免疫方案。在进行的12次融合中,当使用O:6,7 LPS包被的汤普森沙门氏菌作为免疫原时,在小鼠和大鼠中均获得了比使用活细菌、热灭活细菌或O:6,7-BSA糖缀合物作为免疫原时更高产量的产生单克隆抗体的稳定、LPS反应性杂交瘤。当针对一组来自沙门氏菌光滑和粗糙菌株的化学定义的LPS进行ELISA测试时,获得的所有17个杂交克隆均显示与沙门氏菌血清群C1的O抗原结合。讨论了这些结果,以期改进针对细菌LPS抗原生产单克隆抗体的免疫策略。